We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Laser-Based Therapy Could Help Treat Thrombocytopenia

By HospiMedica International staff writers
Posted on 09 Aug 2016
Print article
Image: Purpura, a common symptom of Idiopathic Thrombocytopenia (Photo courtesy of purpurapictures.com).
Image: Purpura, a common symptom of Idiopathic Thrombocytopenia (Photo courtesy of purpurapictures.com).
Low-level laser (LLL) therapy increases the generation of platelets from megakaryocyte precursor cells, according to a new study.

Researcher at Massachusetts General Hospital (MGH; Boston, MA, USA) conducted a study in mice with acute thrombocytopenia, triggered by γ-irradiation. When the mice were exposed to noninvasive, whole-body illumination with a special LLL in the near-infrared (NIR) range, they found that it induced the generation of platelets from megakaryocytes in bone marrow in three different models of thrombocytopenia. The mice healed within two weeks, as opposed to the five-week recovery time required in controls.

LLL treatment increased megakaryocyte size, accelerated the formation of proplatelets, and doubled the production of platelets. LLL also greatly accelerated platelet regeneration in the presence of an anti-CD41 antibody that binds and depletes platelets, and also prevented the severe drop in platelet count caused by chemotherapy. According to the researchers, LLL encourages mitochondrial biogenesis specifically in megakaryocytes owing to the polyploidy of the cells, and also protected them from mitochondrial injury and apoptosis under stress. The study was published on July 27, 2016, in Science Translational Medicine.

“Our study reveals for the first time that low-level laser therapy enhances platelet production in animals with thrombocytopenia, but not in normal controls,” concluded senior author Mei X. Wu, PhD, of the MGH Wellman Center for Photomedicine, and colleagues. “This safe, drug-free, donor-independent modality represents a paradigm shift in the prophylaxis and treatment of thrombocytopenia.”

Thrombocytopenia is a reduction in the platelet count below the normal lower limit, which is usually defined as 150 x 109/L. This can have a variety of causes, including a reduction in platelet production, a reduction in platelet survival, and genetic factors. It is usually treated with blood transfusions. Age, comorbidity, the need for anticoagulation, risk of trauma, and any need for surgery should be taken into consideration when managing people with thrombocytopenia.

Related Links:
Massachusetts General Hospital


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.